IS BMI ASSOCIATED WITH PHARMACODYNAMIC EFFECTS OF SINGLE DOSES OF RABEPRAZOLE 20 MG AND PANTOPRAZOLE 40 MG IN GERD PATIENTS?

(1) Gastroenterology, Nantes University Hospital, Nantes

(2) Gastroenterology, Rouen University Hospital, Rouen, France

(3) Scientific Affairs, Ortho-McNeil Janssen, Raritan, NJ

(4) Scientific Affairs, Eisai Inc, Woodcliff Lake, NJ, United States

(5) Medical Affairs, Janssen-Cilag France, Issy les Moulineaux, France



This item was part of the OESOPHAGEAL, GASTRIC AND DUODENAL DISORDERS II session at Gastro 2009 UEGW/WCOG London (17th UEGW)